{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:30:05Z","timestamp":1791649805773,"version":"4.3.4"},"reference-count":23,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T00:00:00Z","timestamp":1063929600000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:p>Thirty\u2010two <jats:italic>Escherichia coli<\/jats:italic> and 21 <jats:italic>Klebsiella pneumoniae<\/jats:italic> septicemia isolates with varying degrees of resistance to ciprofloxacin were analyzed for the presence of point mutations within the quinolone\u2010resistance target genes. The number of mutations observed in the resistant isolates agreed with the level of ciprofloxacin resistance in both species. Such isolates were also resistant to nalidixic acid. Isolates with borderline susceptibility to ciprofloxacin, on the other hand, behaved differently in the two species. In <jats:italic>E. coli<\/jats:italic> all the isolates harbored at least one mutation and these isolates were also resistant to nalidixic acid, while no mutations were detected in the <jats:italic>K. pneumoniae<\/jats:italic> isolates, and susceptibility to nalidixic acid was unpredictable. Therefore, nalidixic acid cannot be used as a class representative. Time\u2010kill curve studies on an isolate with borderline susceptibility from each species showed higher degrees of resistance to ciprofloxacin in comparison to that of the wild\u2010type <jats:italic>E. coli.<\/jats:italic> A previously unreported <jats:italic>parC<\/jats:italic> mutation, S57\u2192T, was detected in a resistant <jats:italic>E. coli<\/jats:italic> isolate and might expand the QRDR of this gene. Normalized resistance interpretations of histograms confirmed the setting of microbiological zone breakpoints for ciprofloxacin testing.<\/jats:p>","DOI":"10.1034\/j.1600-0463.2003.1110904.x","type":"journal-article","created":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T11:11:16Z","timestamp":1063969876000},"page":"857-866","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Patterns of mutations in target genes in septicemia isolates of <i>Escherichia coli<\/i> and <i>Klebsiella pneumoniae<\/i> with resistance or reduced susceptibility to ciprofloxacin"],"prefix":"10.1111","volume":"111","author":[{"given":"F.","family":"FENDUKLY","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"KARLSSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"HANSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"KRONVALL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"DORNBUSCH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,9,19]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1198-743x.2001.00322.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.4.589"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.2.223"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0805.010204"},{"key":"e_1_2_7_6_2","volume-title":"Antibiotics in Laboratory Medicine","author":"Hooper DC","year":"1991"},{"key":"e_1_2_7_7_2","first-page":"377","article-title":"DNA Gyrase, topoisomerase. IV, and the 4\u2010quinolones","volume":"61","author":"Drlica K","year":"1997","journal-title":"Microbiol Mol Biol Rev"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.7.1994-2000.2001"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1128\/AAC.40.4.879","article-title":"Genetic evidence for a role of parC mutation in the development of high\u2010level fluoroquinolone resistance in Escherichia coli","volume":"40","author":"Heisig P","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.10.2380"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.10.2661"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.2.491"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/39.6.839"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.6.735"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1515-1521.2001"},{"issue":"105","key":"e_1_2_7_16_2","first-page":"13","article-title":"Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing","author":"Olsson\u2010Liljequist B","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/38.3.443"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.7.1609"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2003.00546.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199500492-00037"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.8.2378-2380.2001"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.7.1771-1777.2000"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.710-712.2000"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.6.1247"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0463.2003.1110904.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0463.2003.1110904.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T10:24:07Z","timestamp":1697451847000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0463.2003.1110904.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1034\/j.1600-0463.2003.1110904.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0463.2003.1110904.x","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]},"assertion":[{"value":"2003-09-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}